Pasar al contenido principal

NANOTECNOLOGIA EN HIPERTERMIA TRASLACIONAL

RED2018-102626-T

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Redes Investigación /Redes Excelencia
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION IMDEA NANOCIENCIA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 15
Encontrada(s) 1 página(s)

Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Magnetically activated 3D printable polylactic acid/polycaprolactone/magnetite composites for magnetic induction heating generation

  • Galarreta Rodríguez, Itziar
  • López Ortega, Alberto
  • Garayo Urabayen, Eneko
  • Beato López, Juan Jesús
  • La Roca, Paulo Matías
  • Sánchez-Alarcos Gómez, Vicente
  • Recarte Callado, Vicente
  • Gómez Polo, Cristina
  • Pérez de Landazábal Berganzo, José Ignacio
Additive manufacturing technology has attracted the attention of industrial and technological sectors due to the versatility of the design and the easy manufacture of structural and functional elements based on composite materials. The embedding of magnetic nanoparticles in the polymeric matrix enables the development of an easy manufacturing process of low-cost magnetically active novel polymeric composites. In this work, we report a series of magnetic composites prepared by solution casting method combining 5 to 60 wt.% of 140 ± 50 nm commercial Fe3O4 nanoparticles, with a semi-crystalline, biocompatible, and biodegradable polymeric blend made of polylactic acid (PLA) and polycaprolactone (PCL). The composites were extruded, obtaining 1.5 ± 0.2 mm diameter continuous and flexible filaments for fused deposition modelling 3D printing. The chemical, magnetic, and calorimetric properties of the obtained filaments were investigated by differential scanning calorimetry, thermogravimetric analysis, magnetometry, and scanning electron microscopy. Furthermore, taking advantage of the magnetic character of the filaments, their capability to generate heat under the application of low-frequency alternating magnetic fields (magnetic induction heating) was analyzed. The obtained results expose the versatility of these easy manufacturing and low-cost filaments, where selecting a desired composition, the heating capacity can be properly adjusted for those applications where magnetic induction plays a key role (i.e., magnetic hyperthermia, drug release, heterogeneous catalysis, water electrolysis, gas capture, or materials synthesis)., Open Access funding provided by Universidad Pública de Navarra. This work has been carried out with the financial support of the Navarra Government (project number PC017-018 AMELEC). The Spanish Government is acknowledged for the HIPERNANO research network (RED2018-102626-T). ALO acknowledges financial support from the grants PID2021-122613OB-I00 funded by MCIN/AEI/10.13039/501100011033 and PJUPNA2020 from Universidad Pública de Navarra. P. La Roca has received funding from “la Caixa” and “Caja Navarra” Foundations, under agreement LCF/PR/PR13/51080004.
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

Estimating the heating of complex nanoparticle aggregates for magnetic hyperthermia

  • Ortega Ponce, Daniel
  • Ortega Julia, Javier
  • Leliaert, Jonathan
Understanding and predicting the heat released by magnetic nanoparticles is central to magnetic hyperthermia treatment planning. In most cases, nanoparticles form aggregates when injected in living tissues, thereby altering their response to the applied alternating magnetic field and preventing the accurate prediction of the released heat. We performed a computational analysis to investigate the heat released by nanoparticle aggregates featuring different sizes and fractal geometry factors. By digitally mirroring aggregates seen in biological tissues, we found that the average heat released per particle stabilizes starting from moderately small aggregates, thereby facilitating making estimates for their larger counterparts. Additionally, we studied the heating performance of particle aggregates over a wide range of fractal parameters. We compared this result with the heat released by non-interacting nanoparticles to quantify the reduction of heating power after being instilled into tissues. This set of results can be used to estimate the expected heating in vivo based on the experimentally determined nanoparticle properties.
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

Heating of metallic biliary stents during magnetic hyperthermia of patients with pancreatic ductal adenocarcinoma: an in silico study

  • Bottauscio, Oriano
  • Rubia-Rodríguez, Irene
  • Arduino, Alessandro
  • Zilberti, Luca
  • Chiampi, Mario
  • Ortega Ponce, Daniel
Objective To investigate the eddy current heating that occurs in metallic biliary stents during magnetic hyperthermia treatments and to assess whether these implants should continue to be an exclusion criterion for potential patients. Methods Computer simulations were run on stent heating during the hyperthermia treatment of local pancreatic tumors (5-15 mT fields at 300 kHz for 30 min), considering factors such as wire diameter, type of stent alloy, and field orientation. Maxwell's equations were solved numerically in a bile duct model, including the secondary field produced by the stents. The heat exchange problem was solved through a modified version of the Pennes' bioheat equation assuming a temperature dependency of blood perfusion and metabolic heat. Results The choice of alloy has a large impact on the stent heating, preferring those having a lower electrical conductivity. Only for low field intensities (5 mT) and for some of the bile duct tissue layers the produced heating can be considered safe. The orientation of the applied field with respect to the stent wires can give rise to the onset of regions with different heating levels depending on the shape that the stent has finally adopted according to the body's posture. Bile helps to partially dissipate the heat that is generated in the lumen of the bile duct, but not at a sufficient rate. Conclusion The safety of patients with pancreatic cancer wearing metallic biliary stents during magnetic hyperthermia treatments cannot be fully assured under the most common treatment parameters.
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

Magnetic coagulometry: towards a new nanotechnological tool for ex vivo monitoring coagulation in human whole blood

  • Santana Otero, Antonio
  • Harper, A.
  • Telling, L.
  • Ortega Ponce, Daniel
  • Cabrera, David
Blood clotting disorders consisting of unwanted blood clot formation or excessive bleeding are some of the main causes of death worldwide. However, there are significant limitations in the current methods used to clinically monitor the dynamics of clot formation in human whole blood ex vivo. Here a new magnetic coagulometry platform for testing ex vivo coagulation is described. This platform exploits the sensitivity of the out-of-phase component of alternating current (AC) magnetic susceptibility (χ′′) to variations in mobility and agglomeration of magnetic nanoparticles when trapped during blood clot formation. By labelling human whole blood with magnetic nanoparticles, the out-of-phase component of AC magnetic susceptibility shows that the dynamics of blood clot formation correlates with a decrease in the out-of-phase component χ′′ over time activation of coagulation. This is caused by a rapid immobilisation of nanoparticles upon blood coagulation and compaction. In contrast, this rapid fall in the out-of-phase component χ′′ is significantly slowed down when blood is pre-treated with three different anticoagulant drugs. Remarkably, the system showed sensitivity towards the effect of clinically used direct oral anticoagulation (DOAC) drugs in whole blood coagulation, in contrast to the inability of clinical routine tests prothrombin time (PT) and partial thromboplastin time (PTT) to efficiently monitor this effect. Translation of this nanomagnetic approach into clinic can provide a superior method for monitoring blood coagulation and improve the efficiency of the current diagnostic techniques.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Datos de investigación Set de datos (Dataset)

Radiomag Interlaboratory Comparison of Magnetic Hyperthermia Characterisation Measurements: Data

  • Wells, J. W.
  • Ortega, Daniel
  • Steinhoff, Uwe
  • Dutz, Silvio
  • Garaio, Eneko
  • Sandre, Olivier
  • Natividad, Eva
  • Cruz, M. M.
  • Brero, Francesca
  • Southern, Paul
  • Pankhurst, Quentin A.
  • Spassov, Simo
These files contain the raw measurement data reported for the Radiomag interlaboratory comparison of magnetic hyperthermia characterisation measurements. Each heating curve for samples containing magnetic nanoparticles is presented in a separate excel file detailing the corrected-slope technique (CST) recalculation of the specific loss power and intrinsic loss power for that measurement as described in the manuscript. The measurements are organised into separate folders for Rounds 1 and 2 of the interlaboratory study, with further subfolders dividing the results for samples 1 and 2. Round 2 also includes the results for the “blank” pure water sample which was included in this Round. For each laboratory there is 3 repeated measurements of each sample during each round the study., This data is based upon work supported by the COST action (RADIOMAG TD1402), supported by COST (European Cooperation in Science and Technology). The financial support of the DFG research grants "quantMPI: Establishment of quantitative Magnetic Particle Imaging (MPI) application oriented phantoms for preclinical investigations" (TR 408/9-1) and "Matrix in Vision" (SFB 1340/1 2018, no 372486779, projects A02 and B02) are also gratefully acknowledged. Additional financial support was received from the Spanish Ministry of Economy and Competitiveness through the grants RED2018-102626-T, MAT2017-85617-R, MAT2017-86826-R and the "Severo Ochoa" Program for Centers of Excellence in R&D (SEV-2016-0686). Additional financial support was received from the Portuguese Foundation for Science and Technology (FCT) under UID/MULTI/04046/2013 (BioISI)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Hydrotalcite-Embedded Magnetite Nanoparticles for Hyperthermia-Triggered Chemotherapy

  • Simeonidis, Konstantinos
  • Kaprara, Efthimia
  • Rivera Gil, Pilar
  • Xu, Ruixue
  • Teran, Francisco J.
  • Kokkinos, Evgenios
  • Mitropoulos, Athanassios
  • Maniotis, Nikolaos
  • Balcells, Lluis
A magnetic nanocomposite, consisting of Fe3O4 nanoparticles embedded into a Mg/Al layered double hydroxide (LDH) matrix, was developed for cancer multimodal therapy, based on the combination of local magnetic hyperthermia and thermally induced drug delivery. The synthesis procedure involves the sequential hydrolysis of iron salts (Fe2+, Fe3+) and Mg2+/Al3+ nitrates in a carbonate-rich mild alkaline environment followed by the loading of 5-fluorouracil, an anionic anticancer drug, in the interlayer LDH space. Magnetite nanoparticles with a diameter around 30 nm, dispersed in water, constitute the hyperthermia-active phase able to generate a specific loss of power of around 500 W/g-Fe in an alternating current (AC) magnetic field of 24 kA/m and 300 kHz as determined by AC magnetometry and calorimetric measurements. Heat transfer was found to trigger a very rapid release of drug which reached 80% of the loaded mass within 10 min exposure to the applied field. The potential of the Fe3O4/LDH nanocomposites as cancer treatment agents with minimum side-effects, owing to the exclusive presence of inorganic phases, was validated by cell internalization and toxicity assays, The project was financially supported by Stavros Niarchos Foundation and Eastern Macedonia and Thrace Institute of Technology fellowships for assisting young scientists in prototyping innovative products by using cutting-edge technology. Specific measurements received funding from the EU-H2020 research and innovation programme under grant agreement No. 654360 having benefitted from the access provided by ICMAB-CSIC and Universitat Autonoma de Barcelona in Bellaterra-Barcelona within the framework of the NFFA-Europe Transnational Access Activity. Authors would like to thank Anna Esther Carrillo for the experimental assistance during SEM observations and Bernat Bozzo for the support in SQUID measurements. This work was partially funded by Spanish Ministry of Science, Innovation and Universities (MAT2017-85617-R, SEV-2016-0686, RED2018-102626-T) and Comunidad de Madrid (NANOMAGCOST). COST Actions CA17115 (MyWave), and CA17140 (Nano2Clinic) are also acknowledged. The UPF acknowledges the Ministry of Science, Innovation and Universities (MICINN) and the AEI (RYC-2012-10059, MDM-2014-0370- 04, CTQ2013-45433-PFEDER], MAT2016-75362-C3-2-R, AEI-SAF2015-73052-EXP) and the AGAUR (2017 SGR 1054) for financial support., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Challenges and recommendations for magnetic hyperthermia characterization measurements

  • Wells, James
  • Ortega, Daniel
  • Steinhoff, Uwe
  • Dutz, Silvio
  • Garaio, E.
  • Sandre, Olivier
  • Natividad, Eva
  • Cruz, Maria Margarida
  • Brero, Francesca
  • Southern, Paul
  • Pankhurst, Quentin A.
  • Spassov, Simo
  • RADIOMAG consortium
[Purpose]: The localized heating of magnetic nanoparticles (MNPs) via the application of time-varying magnetic fields – a process known as magnetic field hyperthermia (MFH) – can greatly enhance existing options for cancer treatment; but for broad clinical uptake its optimization, reproducibility and safety must be comprehensively proven. As part of this effort, the quantification of MNP heating – characterized by the specific loss power (SLP), measured in W/g, or by the intrinsic loss power (ILP), in Hm2/kg – is frequently reported. However, in SLP/ILP measurements to date, the apparatus, the analysis techniques and the field conditions used by different researchers have varied greatly, leading to questions as to the reproducibility of the measurements., [Materials and Methods]: An interlaboratory study (across N = 21 European sites) of calorimetry measurements that constitutes a snapshot of the current state-of-the-art within the MFH community has been undertaken. Identical samples of two stable nanoparticle systems were distributed to all participating laboratories. Raw measurement data as well as the results of in-house analysis techniques were collected along with details of the measurement apparatus used. Raw measurement data was further reanalyzed by universal application of the corrected-slope method to examine relative influences of apparatus and results processing., [Results]: The data show that although there is very good intralaboratory repeatability, the overall interlaboratory measurement accuracy is poor, with the consolidated ILP data having standard deviations on the mean of ca. ± 30% to ± 40%. There is a strong systematic component to the uncertainties, and a clear rank correlation between the measuring laboratory and the ILP. Both of these are indications of a current lack of normalization in this field. A number of possible sources of systematic uncertainties are identified, and means determined to alleviate or minimize them. However, no single dominant factor was identified, and significant work remains to ascertain and remove the remaining uncertainty sources., [Conclusion]: We conclude that the study reveals a current lack of harmonization in MFH characterization of MNPs, and highlights the growing need for standardized, quantitative characterization techniques for this emerging medical technology., This article is based upon work supported by the COST action [RADIOMAG TD1402], supported by COST (European Cooperation in Science and Technology). The financial support of the DFG research grants “quantMPI: Establishment of quantitative Magnetic Particle Imaging (MPI) application oriented phantoms for preclinical investigations “(TR 408/9-1) and ‘Matrix in Vision”. [SFB 1340/1 2018, no 372486779, projects A02 and B02] are also gratefully acknowledged. Additional financial support was received from the Spanish Ministry of Economy and Competitiveness through the grants RED2018-102626-T, MAT2017-85617-R, MAT2017-86826-R and the “Severo Ochoa” Program for Centers of Excellence in R&D [SEV-2016-0686]. Additional financial support was received from the Portuguese Foundation for Science and Technology (FCT) under UID/MULTI/04046/2019 (BioISI)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Selective magnetic nanoheating: Combining iron oxide nanoparticles for multi-hot-spot induction and sequential regulation

  • Ovejero, Jesús G.
  • Armenia, Ilaria
  • Serantes, David
  • Veintemillas-Verdaguer, S.
  • Zeballos, Nicoll
  • López-Gallego, Fernando
  • Grüttner, Cordula
  • Fuente, Jesús M. de la
  • Morales, María Del Puerto
  • Grazú, Valeria
The contactless heating capacity of magnetic nanoparticles (MNPs) has been exploited in fields such as hyperthermia cancer therapy, catalysis, and enzymatic thermal regulation. Herein, we propose an advanced technology to generate multiple local temperatures in a single-pot reactor by exploiting the unique nanoheating features of iron oxide MNPs exposed to alternating magnetic fields (AMFs). The heating power of the MNPs depends on their magnetic features but also on the intensity and frequency conditions of the AMF. Using a mixture of diluted colloids of MNPs we were able to generate a multi-hot-spot reactor in which each population of MNPs can be selectively activated by adjusting the AMF conditions. The maximum temperature reached at the surface of each MNP was registered using independent fluorescent thermometers that mimic the molecular link between enzymes and MNPs. This technology paves the path for the implementation of a selective regulation of multienzymatic reactions., This work was funded by the European Commission through the HOTZYMES Project (H2020-FETOPEN-RIA 829162), the Spanish Ministry of Economy and Competitiveness under Grant No. MAT2017-88148-R (AEI/FEDER, UE) and the PIE-201960E062 project, AEI (BIO2017-84246-C2-1-R project to V.G. and J.M.F., and PID2019-109514RJ-100 to D.S.), Nanotechnology in translational hyperthermia (HIPERNANO) - RED2018-102626-T, and Fondo Social de la DGA (grupos DGA)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Unveiling the role of surface, size, shape and defects of iron oxide nanoparticles for theranostic applications

  • Cotin, Geoffrey
  • Blanco-Andujar, Cristina
  • Perton, Francis
  • Asín, Laura
  • Fuente, Jesús M. de la
  • Reichardt, Wilfried
  • Schaffner, Denise
  • Ngyen, Dinh-Vu
  • Mertz, Damien
  • Kiefer, Céline
  • Meyer, Florent
  • Spassov, Simo
  • Ersen, Ovidiu
  • Chatzidakis, Michael
  • Botton, Gianluigi A.
  • Hénoumont, Céline
  • Laurent, Sophie
  • Grenèche, Jean Marc
  • Teran, Francisco J.
  • Ortega, Daniel
  • Felder-Flesch, Delphine
  • Begin-Colin, Sylvie
Iron oxide nanoparticles (IONPs) are well-known contrast agents for MRI for a wide range of sizes and shapes. Their use as theranostic agents requires a better understanding of their magnetic hyperthermia properties and also the design of a biocompatible coating ensuring their stealth and a good biodistribution to allow targeting of specific diseases. Here, biocompatible IONPs of two different shapes (spherical and octopod) were designed and tested in vitro and in vivo to evaluate their abilities as high-end theranostic agents. IONPs featured a dendron coating that was shown to provide anti-fouling properties and a small hydrodynamic size favoring an in vivo circulation of the dendronized IONPs. While dendronized nanospheres of about 22 nm size revealed good combined theranostic properties (r2 = 303 mM s−1, SAR = 395 W gFe−1), octopods with a mean size of 18 nm displayed unprecedented characteristics to simultaneously act as MRI contrast agents and magnetic hyperthermia agents (r2 = 405 mM s−1, SAR = 950 W gFe−1). The extensive structural and magnetic characterization of the two dendronized IONPs reveals clear shape, surface and defect effects explaining their high performance. The octopods seem to induce unusual surface effects evidenced by different characterization techniques while the nanospheres show high internal defects favoring Néel relaxation for magnetic hyperthermia. The study of octopods with different sizes showed that Néel relaxation dominates at sizes below 20 nm while the Brownian one occurs at higher sizes. In vitro experiments demonstrated that the magnetic heating capability of octopods occurs especially at low frequencies. The coupling of a small amount of glucose on dendronized octopods succeeded in internalizing them and showing an effect of MH on tumor growth. All measurements evidenced a particular signature of octopods, which is attributed to higher anisotropy, surface effects and/or magnetic field inhomogeneity induced by tips. This approach aiming at an analysis of the structure–property relationships is important to design efficient theranostic nanoparticles., The Region Alsace, France, and the Labex Chimie des Systemes Complexes, University of Strasbourg, France are gratefully acknowledged for the doctoral fellowship to Geoffrey Cotin. This research project was also co-funded by Labex CSC, Alsace contre le cancer, INCA (project PRTK14, THERAMAG 2014-225) and the INTERREG project NANOTRANSMED. The “NANOTRANSMED” project is co-funded by the European Regional Development Fund (ERDF) and by the Swiss Confederation and the Swiss cantons of Aargau, Basel-Landschaft and Basel-Stadt, in the framework of the INTERREG V Upper Rhine program (“Transcending borders with every project”). The authors thank Morgane Rabineau for epifluorescence imaging and Nadia Messaddeq for TEM imaging of cells. The authors thank the Center for Microscopy and Molecular Imaging (CMMI, supported by the European Regional Development Fund and the Walloon Region). This work was supported by the Fond National de la Recherche Scientifique (FNRS), UIAP VII, ARC Programs of the French Community of Belgium and the Walloon region (Gadolymph and Holocancer programs). All the authors acknowledge the COST action TD1402 “RADIOMAG”. D. Ortega and F. J. Teran acknowledge support from the ‘Severo Ochoa’ Programme for Centres of Excellence in R&D (MINECO, Grant SEV-2016-0686), the Spanish Ministry of Economy and Competitiveness for the NANOLICO project (MAT2017-85617-R), the Spanish Ministry of Science through the NaNoCAR grant PID2020-117544RB-I00, the Ramón y Cajal grant RYC2018-025253-I and Research Networks grant RED2018-102626-T, the HEATOOLS project (BIO2017-84246-C2-1-R), the Comunidad de Madrid for grant NANOMAGCOST (P2018/NMT-4321), DGA for public funding from Fondo Social (grupos DGA), and the European Commission for the funding received through the H2020 “NoCanTher” project (GA No. 685795)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Whither magnetic hyperthermia? A tentative roadmap

  • Rubia-Rodríguez, Irene
  • Santana-Otero, Antonio
  • Spassov, Simo
  • Tombácz, Etelka
  • Johansson, Christer
  • Presa, Patricia de la
  • Teran, Francisco J.
  • Morales, María Del Puerto
  • Veintemillas-Verdaguer, S.
  • Thanh, Nguyen Thi Kim
  • Besenhard, Maximilian O.
  • Wilhelm, Claire
  • Gazeau, Florence
  • Harmer, Quentin
  • Mayes, Eric
  • Manshian, Bella B.
  • Soenen, Stefaan J.
  • Gu, Yuanyu
  • Millán, Ángel
  • Efthimiadou, Eleni K.
  • Gaudet, Jeff
  • Goodwill, Patrick
  • Mansfield, James
  • Steinhoff, Uwe
  • Wells, James
  • Wiekhorst, Frank
  • Ortega, Daniel
This article belongs to the Special Issue Magnetic Nanoparticles as High-Frequency Nano-Heater., The scientific community has made great efforts in advancing magnetic hyperthermia for the last two decades after going through a sizeable research lapse from its establishment. All the progress made in various topics ranging from nanoparticle synthesis to biocompatibilization and in vivo testing have been seeking to push the forefront towards some new clinical trials. As many, they did not go at the expected pace. Today, fruitful international cooperation and the wisdom gain after a careful analysis of the lessons learned from seminal clinical trials allow us to have a future with better guarantees for a more definitive takeoff of this genuine nanotherapy against cancer. Deliberately giving prominence to a number of critical aspects, this opinion review offers a blend of state-of-the-art hints and glimpses into the future of the therapy, considering the expected evolution of science and technology behind magnetic hyperthermia., This work was supported by the NoCanTher project, which has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 685795. The authors acknowledge support from the COST Association through the COST actions “RADIOMAG” (TD1402) and “MyWAVE” (CA17115). D.O., A.S.-O. and I.R.-R. acknowledge financial support from the Community of Madrid under Contracts No. PEJD-2017-PRE/IND-3663 and PEJ-2018-AI/IND-11069, from the Spanish Ministry of Science through the Ramón y Cajal grant RYC2018-025253-I and Research Networks RED2018-102626-T, as well as the Ministry of Economy and Competitiveness through the grants MAT2017-85617-R, MAT2017-88148R and the “Severo Ochoa” Program for Centers of Excellence in R&D (SEV-2016-0686). M.B. and N.T.K.T. would like to thank EPSRC for funding (grant EP/K038656/1 and EP/M015157/1) and AOARD (FA2386-17-1-4042) award. This work was additionally supported by the EMPIR program co-financed by the Participating States and from the European Union’s Horizon 2020 research and innovation program, grant no. 16NRM04 “MagNaStand”. The work was further supported by the DFG grant CRC “Matrix in Vision” (SFB 1340/1 2018, no 372486779, project A02)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Solvothermal synthesis and characterization of ytterbium/iron mixed oxide nanoparticles with potential functionalities for applications as multiplatform contrast agent in medical image techniques

  • Yeste, María Pilar
  • Fernández-Ponce, Cecilia
  • Félix, Eduardo
  • Tinoco, Miguel
  • Fernández-Cisnal, Ricardo
  • García-Villar, Cristina
  • Pfaff, Cathrin
  • Kriwet, Jürgen
  • Natividad, Eva
  • Cauqui, Miguel Ángel
  • García-Cózar, Francisco José
  • Litrán, Rocío
  • Bomatí-Miguel, O.
A solvothermal route to prepare Glutathione capped hybrid ytterbium/iron oxide nanoparticles with potential applications as multiplatform contrast agent in medical image techniques has been developed. The influence of ytterbium/iron molar ratio used as precursor, as well as the degree of the autoclave filling on the structural and morphological characteristics of the obtained nanoparticles has been extensively studied. Although all nanoparticles present similar composition, with YbFeO3 being the majority phase, size and morphology of the as synthetized nanoparticles are highly influenced by the critical temperature and by the over -saturation reached during the solvothermal process. We have demonstrated that glutathione properly functionalizes the hybrid nanoparticles, increasing their colloidal stability and decreasing their cytotoxicity. Additionally, they show good imaging in magnetic resonance and X-ray computerized tomography, thereby indicating promising potential as a dual contrast agent. This work presents, for the first time, glutathione functionalized ytterbium/iron oxide nanoparticles with potential applications in Biomedicine., This work was supported by the Spanish Ministry of Economy and Competitiveness (MAT2015-67354-R) for O.B-M and PID2020-117544RB-I00, for F.G-CPECART-0096-2020, Consejería Salud y Familias. JA Spain; and P20_01293, Consejería Economía, Conocimiento, Empresas y Universidad. JA Spain; for F.G-C; Spanish MCIN/AEI/10.13039/501100011033 (project PID2020-118329RB-I00) for E.N; and MINECO/ FEDER Project MAT2017-87579-R. The authors would like to thank the Nanotechnology in translational hyperthermia RED2018-102626-T network., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The Use of Iron Oxide Nanoparticles to Reprogram Macrophage Responses and the Immunological Tumor Microenvironment

  • Mulens-Arias, Vladimir
  • Rojas, José Manuel
  • Barber, Domingo F.
The synthesis and functionalization of iron oxide nanoparticles (IONPs) is versatile, which has enhanced the interest in studying them as theranostic agents over recent years. As IONPs begin to be used for different biomedical applications, it is important to know how they affect the immune system and its different cell types, especially their interaction with the macrophages that are involved in their clearance. How immune cells respond to therapeutic interventions can condition the systemic and local tissue response, and hence, the final therapeutic outcome. Thus, it is fundamental to understand the effects that IONPs have on the immune response, especially in cancer immunotherapy. The biological effects of IONPs may be the result of intrinsic features of their iron oxide core, inducing reactive oxygen species (ROS) and modulating intracellular redox and iron metabolism. Alternatively, their effects are driven by the nanoparticle coating, for example, through cell membrane receptor engagement. Indeed, exploiting these properties of IONPs could lead to the development of innovative therapies. In this review, after a presentation of the elements that make up the tumor immunological microenvironment, we will review and discuss what is currently known about the immunomodulatory mechanisms triggered by IONPs, mainly focusing on macrophage polarization and reprogramming. Consequently, we will discuss the implications of these findings in the context of plausible therapeutic scenarios for cancer immunotherapy., VM-A is a post-doctoral scholar working under a Juan de la Cierva-Incorporación Contract (IJCI-2017-31447) from the Spanish Ministry of Science and Iion. The European Commission-funded VetBioNet INFRAIA-731014 project supports JR. This work was supported in part by grants from the Spanish Ministry of Science and Innovation (SAF-2017-82223-R and PID-2020-112685RB-100 to DB). DFB group is part of the Network “Nanotechnology in Translational Hyperthermia” (HIPERNANO, RED2018-102626-T) supported by the Spanish Ministry of Science and Innovation., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Enhancing magnetic hyperthermia at the cell membrane by anchoring 92R-functionalized magnetic nanoparticles to low-endocytic CCR9 surface receptors

  • Egea-Benavente, David
  • Corraliza-Gorjón, Isabel
  • Zanten, Thomas S. van
  • Morales, María Del Puerto
  • Kremer, Leonor
  • Barber, Domingo F.
The data that support the findings of this study are available from the corresponding author upon reasonable request., Magnetic hyperthermia therapy (MHT) is a promising cancer treatment that has demonstrated efficacy in phase I and II clinical trials for glioblastoma and prostate cancer. MHT relies on heat generated by magnetic nanoparticles (MNPs) when exposed to alternating magnetic fields (AMFs). The heat output depends not only on the intrinsic properties of MNPs but also on extrinsic factors such as the extracellular and intracellular environments. Aggregation of MNPs under certain conditions can significantly reduce therapeutic efficiency. To overcome this limitation, we present a strategy to enhance MHT by modulating MNP-cell interactions. We functionalized dimercaptosuccinic acid (DMSA)-coated MNPs with the 92R antibody (DMSA-MNPs@92R), which selectively binds to the low-internalization chemokine receptor CCR9, overexpressed in certain tumors. Exposure of CCR9+ MOLT-4 cells to DMSA-MNPs@92R under AMFs resulted in enhanced tumor cell death. Our approach enables spatially controlled binding, maintaining MNPs in a less-aggregated state and at an optimal distance from the cell membrane to maximize heat generation. Mechanistic analysis confirmed that cytotoxicity is driven by localized hyperthermia at the subcellular level rather than a macroscopic temperature increase. These findings underscore the potential of controlled MNPs-cell interactions to improve in vitro MHT performance and open an interesting avenue for enhancing therapeutic efficacy., D.E.-B. is a predoctoral fellow at the Molecular Biosciences Program of the Universidad Autónoma de Madrid supported by the Spanish Ministry of Science and Innovation through a FPI Contract (PRE2018-084189). This work was supported in part by the Spanish Ministry of Science and Innovation through Grant SAF-2017-82223-R (to D.F.B., funded by MCIN/AEI/10.13039/501100011033 and by the ERDF a way of making Europe), PID2019-105404RB-I00 (to L.K., funded by MCIN/AEI/10.13039/501100011033), PID-2020-112685RB-I00 (to D.F.B., funded by MCIN/AEI/10.13039/501100011033), PID2023-150170OB-I00 (to M.P.M., funded by MCIN/AEI/10.13039/501100011033), and PID-2023-146212OB-I00 (to D.F.B, funded by MCIN/AEI/10.13039/501100011033 and by the ERDF, EU). This work was also supported by the CSIC Grant PIE-202320E096 (to L.K.). T.S.v.Z. acknowledges the Severo Ochoa Program for Centres of Excellence, Grant CEX2023-001286-S funded by MICIU/AEI/10.13039/501100011033. The Centro Nacional de Biotecnología (CNB-CSIC) a Severo Ochoa Center of Excellence (CEX2023-001386-S) funded by MICIU/AEI /10.13039/501100011033. The groups of D.F.B. and M.P.M. are part of the “Nanotechnology in Translational Hyperthermia” Network supported by the Spanish Ministry of Science and Innovation (HIPERNANO, RED2018-102626-T, funded by MCIN/AEI/10.13039/501100011033). This research work was performed in the framework of the Nanomedicine CSIC HUB and the CSIC Cancer HUB., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2023-001286-S)., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2023-001386-S)., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Challenges and recommendations for magnetic hyperthermia characterization measurements

  • Wells, J.
  • Ortega, D.
  • Steinhoff, U.
  • Dutz, S.
  • Garaio, E.
  • Sandre, O.
  • Natividad, E.
  • Cruz, M.M.
  • Brero, F.
  • Southern, P.
  • Pankhurst, Q.A.
  • Spassov, S.
  • the, RADIOMAG, consortium
Purpose: The localized heating of magnetic nanoparticles (MNPs) via the application of time-varying magnetic fields–a process known as magnetic field hyperthermia (MFH)–can greatly enhance existing options for cancer treatment; but for broad clinical uptake its optimization, reproducibility and safety must be comprehensively proven. As part of this effort, the quantification of MNP heating–characterized by the specific loss power (SLP), measured in W/g, or by the intrinsic loss power (ILP), in Hm2/kg–is frequently reported. However, in SLP/ILP measurements to date, the apparatus, the analysis techniques and the field conditions used by different researchers have varied greatly, leading to questions as to the reproducibility of the measurements. Materials and Methods: An interlaboratory study (across N = 21 European sites) of calorimetry measurements that constitutes a snapshot of the current state-of-the-art within the MFH community has been undertaken. Identical samples of two stable nanoparticle systems were distributed to all participating laboratories. Raw measurement data as well as the results of in-house analysis techniques were collected along with details of the measurement apparatus used. Raw measurement data was further reanalyzed by universal application of the corrected-slope method to examine relative influences of apparatus and results processing. Results: The data show that although there is very good intralaboratory repeatability, the overall interlaboratory measurement accuracy is poor, with the consolidated ILP data having standard deviations on the mean of ca. ± 30% to ± 40%. There is a strong systematic component to the uncertainties, and a clear rank correlation between the measuring laboratory and the ILP. Both of these are indications of a current lack of normalization in this field. A number of possible sources of systematic uncertainties are identified, and means determined to alleviate or minimize them. However, no single dominant factor was identified, and significant work remains to ascertain and remove the remaining uncertainty sources. Conclusion: We conclude that the study reveals a current lack of harmonization in MFH characterization of MNPs, and highlights the growing need for standardized, quantitative characterization techniques for this emerging medical technology.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Enhancing Magnetic Hyperthermia at the Cell Membrane by Anchoring 92R‐Functionalized Magnetic Nanoparticles to Low‐Endocytic CCR9 Surface Receptors

  • Egea-Benavente, David
  • Corraliza-Gorjón, Isabel
  • Van Zanten, Thomas S.
  • Morales, María del Puerto
  • Kremer, Leonor
  • Barber, Domingo F.
Magnetic hyperthermia therapy (MHT) is a promising cancer treatment that has demonstrated efficacy in phase I and II clinical trials for glioblastoma and prostate cancer. MHT relies on heat generated by magnetic nanoparticles (MNPs) when exposed to alternating magnetic fields (AMFs). The heat output depends not only on the intrinsic properties of MNPs but also on extrinsic factors such as the extracellular and intracellular environments. Aggregation of MNPs under certain conditions can significantly reduce therapeutic efficiency. To overcome this limitation, we present a strategy to enhance MHT by modulating MNP-cell interactions. We functionalized dimercaptosuccinic acid (DMSA)-coated MNPs with the 92R antibody (DMSA–MNPs@92R), which selectively binds to the low-internalization chemokine receptor CCR9, overexpressed in certain tumors. Exposure of CCR9+ MOLT-4 cells to DMSA–MNPs@92R under AMFs resulted in enhanced tumor cell death. Our approach enables spatially controlled binding, maintaining MNPs in a less-aggregated state and at an optimal distance from the cell membrane to maximize heat generation. Mechanistic analysis confirmed that cytotoxicity is driven by localized hyperthermia at the subcellular level rather than a macroscopic temperature increase. These findings underscore the potential of controlled MNPs-cell interactions to improve in vitro MHT performance and open an interesting avenue for enhancing therapeutic efficacy.